1. Anthony Atala was born on July 14,1958 and is an American bioengineer, urologist, and pediatric surgeon.

1. Anthony Atala was born on July 14,1958 and is an American bioengineer, urologist, and pediatric surgeon.
Anthony Atala's work focuses on the science of regenerative medicine: "a practice that aims to refurbish diseased or damaged tissue using the body's own healthy cells".
Dr Atala is the creator of the first 3D bioprinters and is one of the foremost leading figures in the field of organ printing.
Anthony Atala is developing experimental technology that can 3D print human tissue on demand.
Dr Anthony Atala is editor of 3 journals and 25 books including Principles of Regenerative Medicine, Foundations of Regenerative Medicine, Methods of Tissue Engineering and Minimally Invasive Urology.
Anthony Atala has published over 800 journal articles and has received more than 250 national and international patents.
Fifteen technology applications developed in Dr Anthony Atala's laboratory have been used clinically.
Anthony Atala serves on the editorial board of the scientific journal Rejuvenation Research, on the national board of advisors for High Point University and on the SENS Research Foundation's research advisory board.
Anthony Atala is a founding member of the Tissue Engineering and Regenerative Medicine International Society from which he received the Lifetime Achievement Award.
Anthony Atala is the director of the Armed Forces Institute of Regenerative Medicine, a federally funded institute created to apply regenerative medicine.
Anthony Atala was born in Peru and raised in Coral Gables, Florida.
Anthony Atala attended the University of Miami, and he has an undergraduate degree in psychology.
Anthony Atala attended medical school at the University of Louisville, where he completed his residency in urology.
Anthony Atala continued his work in tissue engineering and printable organs after moving to Wake Forest Baptist Medical Center and the Wake Forest School of Medicine in 2004.
Anthony Atala's work was seized on by opponents of the Embryonic Stem Cell Research Bill as a more moral alternative.